Zefotib 250mg Tablet 10s

Introduction to Zefotib 250mg Tablet 10s

Zefotib 250mg Tablet is a medication primarily used to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). It is particularly effective for patients with certain gene mutations called EGFR mutations. This medicine is usually prescribed to patients who have not undergone chemotherapy before.

Composition of Zefotib 250mg Tablet 10s

The active ingredient in Zefotib 250mg Tablet is Gefitinib. Gefitinib is an EGFR tyrosine kinase inhibitor, which means it blocks specific signals that promote cancer cell growth.

Uses of Zefotib 250mg Tablet 10s

• Treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC).
• Specifically targets cancer with EGFR mutations.
• Prescribed for patients who have not received prior chemotherapy.

Side effects of Zefotib 250mg Tablet 10s

Common side effects:

• Diarrhea
• Skin rash
• Nausea
• Vomiting
• Loss of appetite

Serious side effects:

• Liver toxicity
• Lung inflammation
• Severe diarrhea leading to dehydration

Precautions of Zefotib 250mg Tablet 10s

Zefotib should not be used by individuals without EGFR mutations, pregnant or breastfeeding women, or those with severe liver or kidney disease. It is also contraindicated for patients with a history of interstitial lung disease or those allergic to Gefitinib or any of its ingredients.

How to Take Zefotib 250mg Tablet 10s

• Take one tablet orally once daily.
• Consume at the same time each day for consistency.
• Swallow the tablet whole with water; do not crush or chew.
• Follow your doctor's instructions regarding dosage and duration.

Conclusion of Zefotib 250mg Tablet 10s

Zefotib 250mg Tablet is a targeted therapy for treating non-small cell lung cancer with specific gene mutations. While it offers significant benefits, it is essential to be aware of its side effects and take necessary precautions. Always follow your healthcare provider's guidance when using this medication.